171 related articles for article (PubMed ID: 37208133)
1. Study protocol of the InterVitaminK trial: a Danish population-based randomised double-blinded placebo-controlled trial of the effects of vitamin K (menaquinone-7) supplementation on cardiovascular, metabolic and bone health.
Kampmann FB; Thysen SM; Nielsen CFB; Kofoed KF; Køber L; Pham MHC; Vaag A; Jørgensen NR; Petersen J; Jacobsen RK; Kårhus LL; Diederichsen A; Frimodt-Møller M; Linneberg A
BMJ Open; 2023 May; 13(5):e071885. PubMed ID: 37208133
[TBL] [Abstract][Full Text] [Related]
2. Effects of vitamins K2 and D3 supplementation in patients with severe coronary artery calcification: a study protocol for a randomised controlled trial.
Hasific S; Øvrehus KA; Hosbond S; Lambrechtsen J; Kumarathurai P; Mejldal A; Ravn EJ; Rasmussen LM; Gerke O; Mickley H; Diederichsen A
BMJ Open; 2023 Jul; 13(7):e073233. PubMed ID: 37451735
[TBL] [Abstract][Full Text] [Related]
3. Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial).
Vossen LM; Schurgers LJ; van Varik BJ; Kietselaer BL; Vermeer C; Meeder JG; Rahel BM; van Cauteren YJ; Hoffland GA; Rennenberg RJ; Reesink KD; de Leeuw PW; Kroon AA
Nutrients; 2015 Oct; 7(11):8905-15. PubMed ID: 26516910
[TBL] [Abstract][Full Text] [Related]
4. The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: a randomized, double-blind, placebo-controlled trial.
Zwakenberg SR; de Jong PA; Bartstra JW; van Asperen R; Westerink J; de Valk H; Slart RHJA; Luurtsema G; Wolterink JM; de Borst GJ; van Herwaarden JA; van de Ree MA; Schurgers LJ; van der Schouw YT; Beulens JWJ
Am J Clin Nutr; 2019 Oct; 110(4):883-890. PubMed ID: 31387121
[TBL] [Abstract][Full Text] [Related]
5. Effects of menaquinone-7 supplementation in patients with aortic valve calcification: study protocol for a randomised controlled trial.
Lindholt JS; Frandsen NE; Fredgart MH; Øvrehus KA; Dahl JS; Møller JE; Folkestad L; Urbonaviciene G; Becker SW; Lambrechtsen J; Auscher S; Hosbond S; Alan DH; Rasmussen LM; Gerke O; Mickley H; Diederichsen A
BMJ Open; 2018 Aug; 8(8):e022019. PubMed ID: 30139903
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled Trial.
Witham MD; Lees JS; White M; Band M; Bell S; Chantler DJ; Ford I; Fulton RL; Kennedy G; Littleford RC; McCrea IV; McGlynn D; Panarelli M; Ralston MR; Rutherford E; Severn A; Thomson N; Traynor JP; Struthers AD; Wetherall K; Mark PB
J Am Soc Nephrol; 2020 Oct; 31(10):2434-2445. PubMed ID: 32817311
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
8. Effect of vitamin K supplementation on serum calcification propensity and arterial stiffness in vitamin K-deficient kidney transplant recipients: A double-blind, randomized, placebo-controlled clinical trial.
Eelderink C; Kremer D; Riphagen IJ; Knobbe TJ; Schurgers LJ; Pasch A; Mulder DJ; Corpeleijn E; Navis G; Bakker SJL; de Borst MH; Te Velde-Keyzer CA
Am J Transplant; 2023 Apr; 23(4):520-530. PubMed ID: 36695702
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Vitamin K for kidney transplant organ recipients: investigating vessel stiffness (ViKTORIES): study rationale and protocol of a randomised controlled trial.
Lees JS; Mangion K; Rutherford E; Witham MD; Woodward R; Roditi G; Hopkins T; Brooksbank K; Jardine AG; Mark PB
Open Heart; 2020 Jul; 7(2):. PubMed ID: 32675297
[TBL] [Abstract][Full Text] [Related]
11. The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.
Bressendorff I; Hansen D; Schou M; Kragelund C; Brandi L
BMJ Open; 2017 Jun; 7(6):e016795. PubMed ID: 28645983
[TBL] [Abstract][Full Text] [Related]
12. Vitamin K supplementation and bone mineral density in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial.
Levy-Schousboe K; Marckmann P; Frimodt-Møller M; Peters CD; Kjærgaard KD; Jensen JD; Strandhave C; Sandstrøm H; Hitz MF; Langdahl B; Vestergaard P; Brasen CL; Schmedes A; Madsen JS; Jørgensen NR; Frøkjær JB; Frandsen NE; Petersen I; Hansen D
Nephrol Dial Transplant; 2023 Sep; 38(10):2131-2142. PubMed ID: 36460034
[TBL] [Abstract][Full Text] [Related]
13. The effect of six-month oral vitamin K supplementation on calcification propensity time in individuals with type 2 diabetes mellitus: A post hoc analysis of a randomized, double-blind, placebo-controlled trial.
Meer R; Romero Prats ML; Vervloet MG; van der Schouw YT; de Jong PA; Beulens JWJ
Atherosclerosis; 2024 Jul; 394():117307. PubMed ID: 37852868
[TBL] [Abstract][Full Text] [Related]
14. Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): A study protocol for a randomized controlled trial.
Haroon SW; Tai BC; Ling LH; Teo L; Davenport A; Schurgers L; Teo BW; Khatri P; Ong CC; Low S; Yeo XE; Tan JN; Subramanian S; Chua HR; Tan SY; Wong WK; Lau TW
Medicine (Baltimore); 2020 Sep; 99(36):e21906. PubMed ID: 32899022
[TBL] [Abstract][Full Text] [Related]
15. Six months vitamin K treatment does not affect systemic arterial calcification or bone mineral density in diabetes mellitus 2.
Bartstra JW; Draaisma F; Zwakenberg SR; Lessmann N; Wolterink JM; van der Schouw YT; de Jong PA; Beulens JWJ
Eur J Nutr; 2021 Apr; 60(3):1691-1699. PubMed ID: 33068157
[TBL] [Abstract][Full Text] [Related]
16. Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial.
Diederichsen ACP; Lindholt JS; Möller S; Øvrehus KA; Auscher S; Lambrechtsen J; Hosbond SE; Alan DH; Urbonaviciene G; Becker SW; Fredgart MH; Hasific S; Folkestad L; Gerke O; Rasmussen LM; Møller JE; Mickley H; Dahl JS
Circulation; 2022 May; 145(18):1387-1397. PubMed ID: 35465686
[TBL] [Abstract][Full Text] [Related]
17. Impact of menaquinone-4 supplementation on coronary artery calcification and arterial stiffness: an open label single arm study.
Ikari Y; Torii S; Shioi A; Okano T
Nutr J; 2016 May; 15(1):53. PubMed ID: 27175730
[TBL] [Abstract][Full Text] [Related]
18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
19. Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial.
Emaus N; Gjesdal CG; Almås B; Christensen M; Grimsgaard AS; Berntsen GK; Salomonsen L; Fønnebø V
Osteoporos Int; 2010 Oct; 21(10):1731-40. PubMed ID: 19937427
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Magnesium Supplementation on Vascular Calcification in CKD: A Randomized Clinical Trial (MAGiCAL-CKD).
Bressendorff I; Hansen D; Schou M; Kragelund C; Svensson M; Hashemi B; Kristensen T; Vrist MH; Borg R; Tougaard B; Borg K; Hjortkjær HØ; Kristiansen CH; Carlson N; Nasiri M; Ashraf H; Pasch A; Brandi L
J Am Soc Nephrol; 2023 May; 34(5):886-894. PubMed ID: 36749131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
